ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money

February 4, 1983

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

CHOP Evaluation Plan In Jan. 22 Issue

January 15, 1982

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011